PLEASANTON, Calif., July 26, 2017 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:BABY) today announced financial results for the three months ended June 30, 2017.
For the second quarter ended June 30, 2017, the Company reported revenue of $122.2 million, an increase of 27.3% compared to $96.0 million reported for the second quarter 2016. GAAP gross profit margin was 54.1% vs. 59.9% reported for the second quarter 2016. GAAP net loss was $5.0 million, or $(0.15) per diluted share, compared with GAAP net income of $10.5 million, or $0.32 per diluted share in the second quarter 2016.
Non-GAAP earnings per diluted share was $0.34 for the second quarter 2017, compared to $0.39 in the second quarter 2016. Non-GAAP net income was $11.2 million for the second quarter 2017 compared to the prior year's second quarter non-GAAP net income of $12.8 million. Non-GAAP gross profit margin was 60.6% vs. 60.5% reported for the second quarter of 2016.
For the second quarter ended June 30, 2017, the Company reported revenue of $122.2 million, an increase of 27.3% compared to $96.0 million reported for the second quarter 2016. GAAP gross profit margin was 54.1% vs. 59.9% reported for the second quarter 2016. GAAP net loss was $5.0 million, or $(0.15) per diluted share, compared with GAAP net income of $10.5 million, or $0.32 per diluted share in the second quarter 2016.
Non-GAAP earnings per diluted share was $0.34 for the second quarter 2017, compared to $0.39 in the second quarter 2016. Non-GAAP net income was $11.2 million for the second quarter 2017 compared to the prior year's second quarter non-GAAP net income of $12.8 million. Non-GAAP gross profit margin was 60.6% vs. 60.5% reported for the second quarter of 2016.
